"endoscopic mucosal resection (EMR) is used for flat dysplasia/early cancer and endoscopic submucosal dissection (ESD) is used for larger lesions requiring en bloc resection."
"ongoing post-ablation lifelong surveillance and continued PPI treatment are recommended to detect recurrence"
"The annual progression rate from non-dysplastic Barrett oesophagus to oesophageal adenocarcinoma is ~0.3–0.5%/year 12. Low-grade dysplasia carries higher risk (~0.5–1.5%/year) and high-grade dysplasia substantially higher (~7–10%/year) 12."
"The annual progression rate from non-dysplastic Barrett oesophagus to oesophageal adenocarcinoma is ~0.3–0.5%/year 12. Low-grade dysplasia carries higher risk (~0.5–1.5%/year) and high-grade dysplasia substantially higher (~7–10%/year) 12."
"The annual progression rate from non-dysplastic Barrett oesophagus to oesophageal adenocarcinoma is ~0.3–0.5%/year 12. Low-grade dysplasia carries higher risk (~0.5–1.5%/year) and high-grade dysplasia substantially higher (~7–10%/year) 12."
"Oesophageal adenocarcinoma has a 5-year survival ~20% overall, but much improved (~85–95% at T1a stage) if caught at an early/mucosal stage 13."
"History and etymology "
"Barrett oesophagus is named after Norman Rupert Barrett (1903-1979) 11, an Australian-born thoracic surgeon, who first described the condition in 1950 9."
"non-dysplastic Barrett oesophagus is the most common finding: the ESGE 2023 guideline recommends surveillance every 5 years for segments ≥1 cm and"
"the ESGE 2023 and AGA guidelines now recommend:"
"the ESGE 2023 and AGA guidelines now recommend:"
"low grade dysplasia (LGD) confirmed by two pathologists (due to inter-observer variation and the importance of distinguishing from inflammation-related atypia), 6-monthly endoscopy or consideration of RFA"
"low grade dysplasia (LGD) confirmed by two pathologists (due to inter-observer variation and the importance of distinguishing from inflammation-related atypia), 6-monthly endoscopy or consideration of RFA"
"Barrett oesophagus is named after Norman Rupert Barrett (1903-1979) 11, an Australian-born thoracic surgeon, who first described the condition in 1950 9."
Expected headings
"Risk factors"
"Fluoroscopy"
"Treatment"
"Prognosis"
"History and etymology "
"There are regional variations in the specific requirements for recognition of the gastro-oesophageal junction and the histological definition of Barrett oesophagus. Some require intestinal metaplasia with goblet cells."
"Because Barrett oesophagus represents metaplasia, it is often occult on imaging. Early oesophageal adenocarcinoma arising out of Barrett oesophagus may also be difficult to see. No radiological modality is adequate for screening or diagnosis; these rely on endoscopy and biopsy."
"Fluoroscopy has poor sensitivity for early adenocarcinoma and these signs are often subtle or absent; endoscopy with biopsy remains the gold standard."
"localised flattening, stiffening or irregularity in the wall of a stricture"